Ya-Chun Wang


Ph.D., Dept. of Biological Systems Engineering, University of Wisconsin-Madison

MS, Biological Engineering, University of Missouri-Columbia

EMBA, Business Administration, National Taiwan University

Work and Academic Experience:

President, TCM Biotech International Corp. (4/2014-present)

EVP/CSO, TCM Biotech International Corp. (6/2003-3/2014)

Experience: Taiwan Executive Program, (GE program, 2009)

Taiwan TFDA, US FDA, Mainland China CFDA New Drug IND

Director of ITDP grant

Clinical trial conducting and coordination

Strategy partnering development

Establishment of fermentation manufactory

Establishment of R&D center

R&D Director, PhytoHealth Corporation (4/1999-11/2002)

Experience: New drug development

First Botanical Investigational New Drug (IND) approval from TFDA

Pre-clinical study (Chemistry, Manufacture and Control (CMC), Pharmacology, Pharmacokenitic, Toxicity)

New product/technology evaluation

IPO in Taiwan stock exchange

Company value evaluation

SBU Manager, United Biotech Corporation (10/1998-11/2002)

Experience: Chinese new drug development

Dietary supplement, Healthy Food development

Post Doctor, University of Wisconsin-Madison

Selected Presentations and Publication:

1996~2019 total 31 patents, Presentations and Publication articles

Wang, Y-C., Cell-free junctional DNA fragment from hepatitis B virus integration in HCC for monitoring post-resection recurrence and clonaltiy, 2019 ASCO annual meeting, Chicago, US.